Overview

A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy Participants

Status:
Withdrawn
Trial end date:
2024-09-09
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are to compare the pharmacokinetics (PK) and demonstrate relative bioavailability of sotorasib administered as 4 oral tablets (test) to sotorasib administered as 8 oral tablets (reference) and to assess the effect of food on the PK of sotorasib administered as 4 oral tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen
Treatments:
Sotorasib